Skip to main content
. 2022 Sep;23(9):3019–3027. doi: 10.31557/APJCP.2022.23.9.3019

Table 2.

EORTC QLQ-C30 Scores of the Study Participants (N=118)

Item Mean score ± SD n (%)
Scores of <33.3% Scores of ≥66.7%
Global health status/ HRQoL 81.7 ± 18.9 3 (2.5) 88 (74.6)
Functional scalea Role functioning 91.0 ± 17.8 1 (0.8) 98 (83.1)
Social functioning 90.7 ± 21.4 4 (3.4) 101 (85.6)
Emotional functioning 85.0 ± 21.5 4 (3.4) 96 (81.4)
Cognitive functioning 86.7 ± 19.9 1 (0.8) 93 (78.8)
Physical functioning 83.2 ± 19.9 4 (3.4) 97 (82.2)
Symptom scaleb Fatigue 18.9 ± 20.9 88 (74.6) 2 (1.7)
Nausea/vomiting 6.8 ± 14.7 106 (89.8) 1 (0.8)
Pain 20.1 ± 24.2 75 (63.6) 4 (3.4)
Dyspnea 10.7 ± 20.8 89 (75.4) 1 (0.8)
Insomnia 25.1 ± 34.5 67 (56.8) 13 (11.0)
Appetite loss 7.1 ± 15.6 96 (81.4) 0 (0.0)
Constipation 25.4 ± 34.5 67 ( 56.8) 13 (11.0)
Diarrhea 11.1 ± 21.8 88 (74.6) 3 (2.5)
Financial difficulties 12.7 25.0 87 (73.7) 5 (4.2)

EORTC QLQ-C30, European Organization for Research and Treatment of Cancer Quality of Life Questionnaire for Colorectal Cancer-30; SD, Standard Deviation; QOL, Quality Of Life; aFor items in the functional scale, scores of <33.3% were considered to indicate functional difficulties, while scores of ≥66.7% signified good functioning. bFor items in the symptom scale, scores of <33.3% were deemed to indicate less severe symptoms, while scores of ≥66.7% signified more severe and distressing symptoms which could impact QOL.